The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
- 1 February 2013
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 31 (8), 1246-1254
- https://doi.org/10.1016/j.vaccine.2012.12.015
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentationVaccine, 2013
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in FinlandPLOS ONE, 2012
- Complex movement disorders at disease onset in childhood narcolepsy with cataplexyBrain, 2011
- Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in chinaAnnals of Neurology, 2011
- Elevated Tribbles homolog 2–specific antibody levels in narcolepsy patientsJCI Insight, 2010
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2010
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- Narcolepsy: Immunological aspectsSleep Medicine Reviews, 2008
- The General Practice Research DatabaseDrug Safety, 2004
- Narcolepsy in the Older AdultDrugs & Aging, 2003